• Tonix Pharmaceuticals CEO Seth Lederman reported buying 2,000 common shares at $13.79 through an IRA account.
• IRA-held stake rose to 11,005 shares following the purchase.
• Lederman also reported direct ownership of 20,001 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tonix Pharmaceuticals Holding Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040736), on August 31, 2026, and is solely responsible for the information contained therein.